Reduced Annexin A3 in schizophrenia (2020)
Source: European archives of psychiatry and clinical neuroscience. Unidade: FM
Subjects: ESQUIZOFRENIA, TRANSTORNO BIPOLAR, BIOMARCADORES, PROTEÍNAS DE LIGAÇÃO DO CÁLCIO
ABNT
JOAQUIM, Helena P. G et al. Reduced Annexin A3 in schizophrenia. European archives of psychiatry and clinical neuroscience, v. 270, n. 4, p. 489-494, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00406-019-01048-3. Acesso em: 27 set. 2024.APA
Joaquim, H. P. G., Costa, A. C., Serpa, M. H., Talib, L. L., & Gattaz, W. F. (2020). Reduced Annexin A3 in schizophrenia. European archives of psychiatry and clinical neuroscience, 270( 4), 489-494. doi:10.1007/s00406-019-01048-3NLM
Joaquim HPG, Costa AC, Serpa MH, Talib LL, Gattaz WF. Reduced Annexin A3 in schizophrenia [Internet]. European archives of psychiatry and clinical neuroscience. 2020 ; 270( 4): 489-494.[citado 2024 set. 27 ] Available from: https://doi.org/10.1007/s00406-019-01048-3Vancouver
Joaquim HPG, Costa AC, Serpa MH, Talib LL, Gattaz WF. Reduced Annexin A3 in schizophrenia [Internet]. European archives of psychiatry and clinical neuroscience. 2020 ; 270( 4): 489-494.[citado 2024 set. 27 ] Available from: https://doi.org/10.1007/s00406-019-01048-3